Free Trial

Korro Bio (KRRO) Competitors

Korro Bio logo
$42.15 -6.45 (-13.27%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$42.06 -0.09 (-0.23%)
As of 10/17/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KRRO vs. VCEL, JANX, EWTX, RCUS, HRMY, AUPH, PAHC, SDGR, HROW, and SNDX

Should you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include Vericel (VCEL), Janux Therapeutics (JANX), Edgewise Therapeutics (EWTX), Arcus Biosciences (RCUS), Harmony Biosciences (HRMY), Aurinia Pharmaceuticals (AUPH), Phibro Animal Health (PAHC), Schrodinger (SDGR), Harrow (HROW), and Syndax Pharmaceuticals (SNDX). These companies are all part of the "pharmaceutical products" industry.

Korro Bio vs. Its Competitors

Vericel (NASDAQ:VCEL) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Vericel has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.89, indicating that its stock price is 189% more volatile than the S&P 500.

Vericel has higher revenue and earnings than Korro Bio. Korro Bio is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vericel$237.22M7.51$10.36M$0.12294.33
Korro Bio$2.27M174.36-$83.58M-$9.75-4.32

In the previous week, Vericel had 12 more articles in the media than Korro Bio. MarketBeat recorded 15 mentions for Vericel and 3 mentions for Korro Bio. Korro Bio's average media sentiment score of 0.42 beat Vericel's score of 0.36 indicating that Korro Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vericel
3 Very Positive mention(s)
3 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Korro Bio
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

13.2% of Korro Bio shares are owned by institutional investors. 7.2% of Vericel shares are owned by company insiders. Comparatively, 4.6% of Korro Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Vericel has a net margin of 2.85% compared to Korro Bio's net margin of 0.00%. Vericel's return on equity of 2.47% beat Korro Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Vericel2.85% 2.47% 1.69%
Korro Bio N/A -61.51%-42.87%

Vericel presently has a consensus target price of $58.40, indicating a potential upside of 65.35%. Korro Bio has a consensus target price of $86.83, indicating a potential upside of 106.01%. Given Korro Bio's stronger consensus rating and higher probable upside, analysts clearly believe Korro Bio is more favorable than Vericel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vericel
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.71
Korro Bio
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.00

Summary

Vericel beats Korro Bio on 9 of the 17 factors compared between the two stocks.

Get Korro Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRRO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KRRO vs. The Competition

MetricKorro BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$395.79M$2.62B$6.13B$10.55B
Dividend YieldN/A57.79%5.72%4.83%
P/E Ratio-4.3223.3185.7827.06
Price / Sales174.36778.09612.92132.30
Price / CashN/A27.2425.8230.35
Price / Book2.465.3212.226.58
Net Income-$83.58M$33.06M$3.33B$276.84M
7 Day Performance-7.79%-0.91%0.67%-0.72%
1 Month Performance16.92%7.35%6.88%2.16%
1 Year Performance-47.34%-5.13%58.88%34.63%

Korro Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KRRO
Korro Bio
2.2333 of 5 stars
$42.15
-13.3%
$86.83
+106.0%
-47.3%$395.79M$2.27M-4.3270Positive News
VCEL
Vericel
3.34 of 5 stars
$33.49
+5.1%
$60.40
+80.4%
-15.2%$1.61B$237.22M279.11300News Coverage
Analyst Upgrade
Analyst Revision
JANX
Janux Therapeutics
2.6612 of 5 stars
$26.29
-0.8%
$78.31
+197.9%
-46.5%$1.59B$10.59M-14.6130
EWTX
Edgewise Therapeutics
3.132 of 5 stars
$14.71
-2.6%
$38.83
+164.0%
-57.7%$1.59BN/A-9.4960
RCUS
Arcus Biosciences
2.3976 of 5 stars
$16.64
+14.0%
$26.78
+61.0%
-10.6%$1.55B$258M-5.25500Gap Up
HRMY
Harmony Biosciences
4.7611 of 5 stars
$26.36
-0.7%
$46.11
+74.9%
-26.9%$1.53B$714.73M8.50200Analyst Forecast
AUPH
Aurinia Pharmaceuticals
2.8523 of 5 stars
$11.10
-1.5%
$13.00
+17.1%
+64.3%$1.48B$235.13M25.81300Positive News
PAHC
Phibro Animal Health
3.8793 of 5 stars
$36.58
+0.5%
$28.40
-22.4%
+65.0%$1.48B$1.30B31.002,475
SDGR
Schrodinger
3.5947 of 5 stars
$19.70
+3.2%
$26.29
+33.4%
+8.5%$1.40B$207.54M-7.94790News Coverage
Analyst Forecast
HROW
Harrow
2.9772 of 5 stars
$38.77
+3.4%
$68.50
+76.7%
-30.4%$1.39B$199.61M-155.08180Positive News
Gap Down
SNDX
Syndax Pharmaceuticals
4.0138 of 5 stars
$15.20
-5.4%
$39.22
+158.0%
-27.4%$1.38B$23.68M-3.91110Trending News
Analyst Revision

Related Companies and Tools


This page (NASDAQ:KRRO) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners